Ikena Oncology Inc (IKNA)
1.71
-0.02
(-1.16%)
USD |
NASDAQ |
Nov 22, 16:00
1.69
-0.02
(-1.17%)
After-Hours: 20:00
Ikena Oncology Cash from Operations (Quarterly): -8.938M for Sept. 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -8.938M |
| June 30, 2024 | -12.50M |
| March 31, 2024 | -18.30M |
| December 31, 2023 | -21.82M |
| September 30, 2023 | -20.00M |
| June 30, 2023 | -18.14M |
| March 31, 2023 | -19.78M |
| December 31, 2022 | -17.66M |
| September 30, 2022 | -17.22M |
| June 30, 2022 | -19.45M |
| Date | Value |
|---|---|
| March 31, 2022 | -19.78M |
| December 31, 2021 | -13.37M |
| September 30, 2021 | -17.99M |
| June 30, 2021 | -15.72M |
| March 31, 2021 | -13.17M |
| December 31, 2020 | -12.57M |
| September 30, 2020 | -7.67M |
| June 30, 2020 | -7.712M |
| March 31, 2020 | -9.874M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-21.82M
Minimum
Dec 2023
-7.67M
Maximum
Sep 2020
-15.35M
Average
-17.22M
Median
Sep 2022
Cash from Operations (Quarterly) Benchmarks
| MediciNova Inc | -2.811M |
| NovaBay Pharmaceuticals Inc | -2.061M |
| Palatin Technologies Inc | -7.016M |
| iBio Inc | -3.715M |
| Theriva Biologics Inc | -3.913M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 9.454M |
| Free Cash Flow | -61.56M |
| Free Cash Flow Per Share (Quarterly) | -0.1852 |
| Free Cash Flow Yield | -74.75% |